Stromedix acquisition signals growing interest in fibrosis

Nat Biotechnol. 2012 May 7;30(5):375-6. doi: 10.1038/nbt0512-375.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antigens, Neoplasm / immunology
  • Biomedical Research / economics*
  • Biomedical Research / trends
  • Biotechnology / economics*
  • Biotechnology / trends
  • Commerce
  • Europe
  • Fibrosis / drug therapy*
  • Humans
  • Integrins / immunology
  • Lung / drug effects
  • United States

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Integrins
  • integrin alphavbeta6